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Abstract 
Mineral deposits from human aortas and 
bioprosthetic devices implanted in experimental 
animals show close similarities in chemical 
compost ti on, solubility and structural 
characteristics. Chemical analyses show 
compositions correspondinq to a Na, Mg, co 3 
substituted apatitic calcium phosphate. 
Synergistic XRO, FT- IR and Raman Mi crop robe 
spectroscopic data provided coherent indication 
of Type-B col- incorporation. Microscopic and 
electron microprobe microanalyses, however, 
indicate substantial morphological and spatial 
heterogeneity in the deposits. 
Solubility and kinetic dissolution data of 
the mineral fraction of deposits can be compared 
with the corresponding data of octaca 1 ci um 
phosphate (OCP). This may indicate that OCP is 
a possible precursor phase which initiates 
formation of the mineral deposit. Our data 
i ndi ca te that the deposits can be represented by 
a serf es of ca rbona te-substi tuted products, 
arisinq from OCP that has hydrolyzed to varying 
degrees. Dissolution of deposits can be 
described kinetically as a surface controlled 
rate process. The similarities in the two types 
of deposits suqgest that they form by a common 
me cha ni sm (e.g., OCP could be the precursor for 
both deposits). 
Key words: Carbonate apatite, cardiovascular 
deposits, dissolution rates, electron probe 
microanalysis, infrared spectroscopy, octa-
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Introduction 
Pathological calcification is a widely 
recognized phenomenon that adversely affects the 
quality and span of human life. It may result 
as a consequence of a whole spectrum of 
pathological conditions and may occur in many 
organs and tissues in the body. One of the most 
common sites is the cardiovascular system, 
specifically the aorta. Modern bioprosthetic 
devices and implants have very important uses in 
cardiovascular systems; however, the functions 
of the devices may be impaired by formation of 
calcified deposits. The severity of the problem 
has prompted considerable research on 
understanding the cause and nature of the 
calcifications. There is a considerable body of 
information concerning atherosclerotic and 
bioprosthetic calcifications deriving from 
analytical [2], x-ray and electron diffraction 
[2,23,24], and quantitative electron microprobe 
analysis [8,23,25,31] data. The formation of 
biomineral is an extremely complex process, the 
study of which has led to the development of 
several models for their formation. Montel et 
al. [29] discuss formation of the mineral 
component of calcified tissue by analogy with 
synthetic systems. Eanes et al. [11] studied 
calcium phosphate precipitation in multilamellar 
liposome suspensions as a possible model for 
matrix vesicle mineralization. Boskey and 
Posner [3] provided experimental evidence that 
phospholipids control calcium phosphate 
formation in synthetic systems, and the presence 
of phospholipids in atherosclerotic deposits 
[10] supports this model for biomineralization. 
There is considerable difference of opinion 
regarding the composition of cardiovascular 
mineral deposits. Cichocki et al. [7] used the 
proton induced x-ray emission (PIXE) method to 
provide detailed elemental analyses of human 
atherosclerotic artery wall without addressing 
the question of the identity of the deposits. 
Krefting et al. [25] produced a detailed 
electron microprobe atlas of mineralized aortas 
and suggested that the subiritimal band is the 
primary site for mineral deposition. 
This contribution provides comparative 
information on composition and structure of 
aortic and bioprosthetic calcifications in order 
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to better understand the mechanism of deposit 
formation, with the ultimate goal of developing 
protocols for its prevention. Thermodynamic 
solubility and dissolution kinetic data comple-
ment the classical physicochemical characteri-
zation methods to pro vi de more comp 1 ete i nfor-
ma ti on on pathologic minerals and their possible 
precursors. 
Materials* and Methods 
Two types of deposits have been examined: 
(a) atherosclerotic calcified plaque isolated 
from the intima layer from human subjects and 
(b) bioprosthetic calcifications occurring on 
surfaces of left ventricular assist devices 
(LVAD) implanted into experimental animals. The 
details of isolation, treatment, quantitative 
deproteination and storage of materials used in 
these studies will he described subsequently 
(Tomazic et al., manuscript to he submitte<i to 
Atherosclerosis). Chemical analyses were 
performed by dissolving deproteinated deposits 
and determining the Ca, Na, Mg, K, Sr and Ph 
contents by atomic absorption spectroscopy. 
Phosphate contents were determined spectro-
photometrically using the molybdate-vanadate 
method [18]: HP04 2- content was estimated after 
pyrolysis of deposits (24 h, 4050C, 0.1 torr), 
from the difference in spectrophotometric 
readinqs from hydrolyzed and unhydrolyzed 
aliquots [17]. Carbonate content in the 
deposits was <letermined by microtitration using 
a modifie<l Conway microdiffusion method rq7_ 
X-ray diffraction (XRD) patterns were recorded 
using a Philips automated Powder Diffractometer, 
ADP 3600. The powder patterns were compared 
with the Joint r:ommittee of Powder Diffraction 
Standards values for representative calcium 
phosphate compoun<ls. Infrared spectra of 
deproteinated deposits (2 mg/400 mg KBr pellet) 
were recor<led using a Nicolet 7000 series FT-IR 
spectrophotometer. Direct molecular information 
on structure and composition has been gained 
from investigations using conventional FT-IR and 
Raman microprohe spectroscopy. 
Raman microprobe analysis was performed 
with the microprobe develope<l at the National 
Bureau of Standards [ 14 J. The instrument 
employs an Ar+/Kr+ gas laser to excite the 
spectra with 514.5 nm excitation. The 
measurements were performed on powdered samples 
of these calcified deposits. Spectra of single 
particles (size ranqe 5-50 µm) of the powders 
dispersed on lithium fluoride substrates were 
recorded. Laser power densities directed at 
these samples ranged from 5-20 mW in a beam spot 
of 10 µm diameter. The native, non-depro-
tei na terl samples of these deposits showed some 
*Certain commerc, a 1 ma teri a 1 s and equipment are 
identified in this paper to specify the 
experimental proce<lure. In no instance <loes 
such identification imply recommendation or 
endorsement by the National Bureau of Standards 
or the ADA Health Foundation or that the 
material or equipment identified is necessarily 
the best available for the purpose. 
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mild luminescence upon initial exposure to the 
focused laser spot which quickly diminished upon 
continued irradiation providing acceptable 
spectral background levels. Al 1 spectra were 
recorded with 5 cm-1 spectral resolution. We 
examined the spectra of various calcium 
phosphates, including hydroxyapatite (HAP), 
ca 10(P04 )6
(0H) 2, octacalcium phosphate (OCP), 
ca 8H2(P04 J6 , and amorphous calcium phosphate (ACPJ. In addition, a series of synthetic 
carbonate apatites, of the Type-A and Type-B 
variety, allowed us to examine the spectral 
patterns for the contri buti ans by col- in the 
two lattice sites. The Type-B carbonate 
apatites consist of a series of preparations 
with col- contents varying from 1.5 to 16 
wt %, 'and these were used as calibration 
standards in an empirical scheme to determine 
carbonate contents. Optical properties of 
deposits were examined by using a Leitz Ortholux 
polarizing microscope. Cross sections of 
fractured pieces of atherosclerotic deposits 
were examined by scanning electron microscopy 
(SEM) using a Cambridge 250 Mark II scanning 
electron microscope equipped with a Princeton 
Gamma-Tech rnx system. Samples were placed on 
an aluminum stub, gold plated and scanned (lo-6 
torr, 20 keV, tilting angle QO). The 
compositions of selected areas of deposits were 
estimated after appropriate background 
corrections. 
Solubility and dissolution-kinetic data 
were obtained by suspending finely ground 
deprotei na ted deposits into diluted phosphoric 
acid solutions at the desired solid/solution 
ratios. Systems were purged with C02/N2 gas 
mixtures in order to suppress the loss of CO2 
from the dissolving medium and to assure 
reproducible control of pH. Different C02/N2 
mixtures (0.15-33%) were used to investigate the 
dependency of rate of equilibration on solution 
carbonate concentration. The analytical 
concentrations of supernatants of the 
equilibrating systems were determined by methods 
outlined above. The concentration data were 
used for calculation of ionic activity products 
( IAP) and pIAP (defined in Table 1) for 
di calcium phosphate di hydrate (DCPD), 
CaHP04 -2H20, OCP, /3-tricalcium phosphate 
(/3-TCP), {3-Ca3(P0 4 ) 2 , and HAP. Calculations 
were performed by using a program which ta~es 
into account calcium phosphate complex ,on 
equilibria in the aqueous phases [28] with 
emphasis on carbonate speciation and complex 
formation. The calculated ionic activity data 
were used to provide addi ti ona 1 i nforma ti on on 
the identity of mineral components in 
cardiovascular deposits. Three approaches were 
attempted: (a) comparison of IAP's with the 
corresponding solubility product values of 
calcium phosphates listed above, (b) application 
of chemical potential plots p(H+)3(Po 4
3-) vs. 
p(ca2+)(0H-) 2 [28] to characterize the solutions 
obtained in successive equilibrations; these 
provided new information on the chemical nature 
of deposits, and (c) kinetic treatment of 
dissolution data to test the findings of {a) and 
{h). 
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TABLE 1 
Ionic Activity Products Obtained by Reequilibrations of 
Deproteinated Aortic Deposit 10-Hy. 
Ref. 
Co11pound pIAP st.dev. pKsp I Condition for pKsp 
OCP 48.49 0.45 49.5 2.0 ss ( 35) 
OCP 48.49 0.45 48.6 0.2 ss (22) 
/3-TCP 29.23 0.41 28.91 -0. 1 us ( 20) 
HAP 5 3. 18 0. 77 58.55 9. 2 ss ( 28) 
DCPD 6. 9 2 0.05 6.60 -4.8 us ( 19) 
pIAP(DCPD) -log [(Ca2+)(HPo 4 -JJ 
pIAP(OCP) -log [(ca2+)4(po 4 3-J3(H+)J 
p I AP (/3- TCP) - 1 o g [ ( Ca 2 + ) 3 ( PO 4 3 - ) 2 ] 
pIAP(HAP) -log [(ca2+)5(P043-J3(oH-J] 
% = ~sp-pIAPxlOO 
pKsp 
ss = supersaturated;%> O 
US = undersaturated; % < 0 
TABLE 2 
Chemical Compositions of Deproteinated Atherosclerotfc (A) and Biopros-
thetfc (8) Deposits, Expressed in Molar Ratios with Standard Deviations. 
n Ca/P Mg/P Na/P C03/P I C03 Ch. Bal. 
(A) 10 1 . 7 3 0.043 0.063 0.244 6.99 0.142 
( 0. 06) (0.007) (0.006) (0.024) ( 0. 59) (0.076) 
( B) 3 1 . 7 5 0.048 0.047 0.238 6. 91 0. 1 59 
( 0. 08) ( 0. 00 3) ( 0. 0 20) ( 0. 01 7) ( 0. 37) ( 0. 134) 
Results 
Chemical Composition 
The average results from detailed chemical 
analyses of 10 rleproteinatect atherosclerotic and 
three deproteinated bioprosthetic deposits, with 
correspondinq stanrlard ctevi ati ons, are outl inect 
in Table 2. The compositions are very similar 
regardless of the fact that the human aortic 
deposits (patient age group 45-80 y) generally 
develop over a much longer time period than 
hioprosthetic deposits (up to five months). 
Analyses of four native aortic deposits and four 
native bioprosthetic materials showed HPo4= 
contents of 3.0% (s = 0.7%) anct 2.8% (s = 0.8%) 
of total phosphate, respectively. Kuhl and 
Nebergall [26) suggested that the composition of 
nonstoichiometric carbonate apatite can he 
expressed as follows: 
Ca10-x-y(P04l5-x(HP04,C03lx(OHl2-x- 2Y· 
When the ctata from Table 2 are translated into 
such an expression, the composition of aortic 
deposit becomes: 
Ca8.66Mgo.22Nao.32Ho.15(P04)5(C03l1.22 
(OH, C 1 , F) o . 8, 
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SEM and EDX Data 
SEM provided information suggesting that 
the inorqanic matrix may be spatially 
heterogeneous. This is well illustrated in Fig. 
l a-c. The chemical compositions of cteposits 
with representative morphologies were determined 
by EDX and are representect as usual by the Ca/P 
ratios, as follows: Fig. la: smooth spherical 
particles, Ca/P 1.56; Fig. lb: irregular 
particles of rather constant size, Ca/P = 1.68; 
Fig. le: layer type scale (most abundant), Ca/P 
l. 79. The morphological findings are in 
accord with observations of Schmid et al. [33) 
who as sumect that "the surface of the ctepos its 
have a composition essentially the same as the 
entire deposit," which may be an 
oversimplification. 
X-ray Diffraction Analysis 
X-ray diffraction characterization of 
cardiovascular deposits provides limiterl 




Ca/P = 1. 79. 
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Scanning electron micrographs of 
deprotefnated. atherosclerotic 
Ca/P = 1.56; (b) Ca/P = 1.68; (c) 
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atherosclerotic and bioprosthetic deposits are 
practically identical. Materials are 
microcrystalline, in accordance with other 
reports [24,33] XRD yiel<1e<1 apatitic patterns, 
compatible with those of HAP and OCP, but devoid 
of lines characteristic of DCPD, ,B-TCP, or 
whitlockite. Calculations of lattice parameters 
show an average 0.47% decrease in the a-axis and 
a 0.03% increase in the c-axis. This is in 
accord with the proposed carbonate-for-phosphate 
substitution (Type-8) in the hexagonal apatitic 
structure [27] and our finding of average 7% 
carbonate content in the rleposits. 
IR-Spectroscopic Analysis 
FT-IR spectra of atherosclerotic and 
bi opros thet i c dep rotei na terl depos i ts a re shown 
in Fig. 2. The spectra are very similar and 
show absorption bands at 872, 1417, 1452 and 
1470 cm-1 which can be assignerl to carbonate 
substituting for phosphate in the apatitic 
(Type-8) structures [12,13,27]. The absence of 
the 1545 cm-1 band assignable to carbonate 
substituted for hydroxyl [SJ is significant 
because it indicates minimal or absence of 
Type-A substitution. 
Ra1111.n Microprobe Analysis 
The application of Raman microprobe 
spectroscopy to these i nves ti ga ti ons represents 
an extension of earlier micro-Raman work on 
mineralizing biological tissues, which had shown 
that such measurements can be performed 
nonintrusively and that the spectra lend 
themselves to useful interpretation [5,15,21]. 
The primary goal was to obtain corroborative 
molecular-specific information on the apatitic 
phase, especially with respect to the type of 
carbonate substitution (substitution of C032-
for either Po43- or OH-, or both) in these 



















Fig. 2. COllll)aratfve FT-IR adsorption spectra of 
deproteinated atherosclerotic (1) and 
bioprosthetic (2) deposits. 2 111!J sample/400 111g 
KBr pellet. 
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attempt is made here to quantify carbonate 
contents from the scattering rlata obtained in 
the microscopic rlomain. Presenterl are the 
micro-Raman spectra (Fig. 3) of deproteinated 
aortic plaque and that of a synthetic Type-B 
carbonate apatite with 4.3% carbonate content. 
Human Aortic Plaque 
(deproteinated) 
Carbonate Apatite, Type B 
(synthetic,,-,4.3 wt% COf) 
3500 3100 2700 1200 800 








Fig. 3. Microparticle Ranan spectra of (i) 
hUllllln aortic deposit deprotefnated by hydrazine 
treatment and (ii) synthetic Type-8 carbonate 
apatite (4.3% w/w carbonate). Spectra of single 
particles (~ 20 µm size) supported on a LiF 
substrate. Excitation at 514.5 nm; partial 
spectral range. 
The spectra display a striking similarity anrl 
are a true reflection of the similarities in the 
composition and molecular structure of the 
biological versus the synthetic carbonate 
apatite. The principal features in both of 
these spectra arise from the Raman active 
vibrations of the P043- and col- ions. The 
internal vibrational morles of the phosphate 
group give rise to shifts to about 961 cm- ( v1 
P-0 symmetric stretch), 432 anrl 455 cm-1 ( v 2 
morles), 582, 593 and 610 cm-1 (v 4 modes), and 
1030, 1048 anrl 1079 cm-1 ( v 3 morles). The r:oi-
group in the synthetic carbonate apatite has as 
its strongest feature a band at ~1075 cm-1 (v 1 
C-0 symmetric stretch) characteristic of Type-B 
substitution in the lattice. The equivalent 
carbonate banrl ( v,) in fully substituted Type-A 
99 
carbonate apatite, ca 10(P04 )6co3 , containing 5.8 
wt% co/-, appears at frequency shift of 1110 
cm-1: thus, it can readily be distinguisherl from 
its Type-B counterpart. The weak bands centered 
at ~2920 cm-1 and at ~3575 cm-1 are attributed 
to 0-H stretching modes of the hydroxyl ions in 
the carbonate apatite. In the spectrum of the 
aortic plaque, the weak hanrl with maximum at 
~2940 cm-1 is assigned to C-H stretching 
vibrations, this band being a weak remnant of 
the incompletely removed organic matrix. 
Carbonate contents of these calcified rleposits 
are determined by an empirical procerlure 
utilizing the scattering data from a series of 
synthetic carbonate apatites. This involves 
determining the intensity ratios of the ~1075 
cm-1 carbonate band and the ~961 cm-1 phosphate 
band, with appropriate corrections for the 
spectral "backgrounrl" at each of these 
analytical frequencies. 
This method of quantitation of carbonate 
contents of the mineral phase of human aortic 
plaque yields an average concentration of 6.2 wt 
% co32- based on the measurement of several 
arbitrary, single particles. Similar results, 
with an average value of 6.4 wt % col-, were 
obtained for deprotei na ted bi opros thet, c p 1 aque 
based on an equal number of particle 
measurements. 
Optical Microscopy Analysis 
Optical microscopic examinations of 
pul veri zerl deposits provided addi ti ona 1 data in 
accord with the view that the material is 
relaterl to OCP. Generally, the materials were 
morphologically heterogeneous, displaying weak 
birefrinqency. Aortic deposits were represented 
mostly by three morphologies resembling square 
shaped agg·1 omera tes, "coa 1-1 i ke" conglomerates 
with "diamonds" inside, and irregular particles. 
The refraction index, N, for the majority of the 
particles was about 1.58, ranging from 
1.55-1.59. 8ioprosthetic deposits comprised 
more homogeneous populations of particles with 
sliqht "length slow" birefringence and with 
refraction indices above 1.55, but below 1.59. 
The observed refraction indices can be compared 
with the OCP values N0 = 1.576, N13 = 1.583 and 
N-y = 1.585 and are in sharp contrast to the HAP 
values, Nt 1 .64 and Nw = 1.646 [41. The 
refractive indices of carbonate-substituted 
apatites cover a range from 1.61-1.64 [11, i.e., 
less than the corresponding HAP indices; by 
analogy, that suggests that the deposits 
represent a continuum of carbonate-containing 
hydrolytic products of OCP. 
Solubility of Deposits 
The results of eight successive equili-
brations of a deproteinated atherosclerotic 
deposit (sample 10-Hy) with 1 mM H3Po4 (20 g/L, 
5% CO2, Exp. E-8) are shown in Fig. 4. The 
first equilibration resulted in substantial 
1 ea chi ng of Na and Mg from the deposits. After 
the fourth equilibration the solution 
concentrations became relatively constant, and 
Na and Mg leachinq was greatly reduced. This 
behavior suqges ts that a ma .ior portion of Na and 
Mg is surface bound. The pIAP values for 
various calcium phosphates were calculated 



























Fig. 4. Repeated equilibrations of athero-
sclerotfc deproteiMted deposit sample 10-Hy 
with 1 ""1 H3Po4 (20 g/L. 51 CO2• Exp. E-8). 
o Ca. □ P. ,:,.Na. • Mg concentration and 'J pH 
data; ,. pIAP(OCP) data to be collll)ared with 
pKsp(OCP) values 1: 49.5 (ref. [22]) and 2: 
48.5 (ref. [35)). 
following each equilibration, and the trend of 
p!AP(OCP) is shown in Fig. 4. The calculated 
values fall mostly between the two recently 
reported values of pKsp(OCP) = 49.5 [22] and 
48.6 [35]. A summary of the average values of 
p!AP, the corresponding standard deviations, and 
the corresponding supersaturation/undersatu-
ration values for equilibrated suspensions is 
given in Table 1. At apparent equilibrium, the 
suspensions are very close to saturation with 
respect to OCP and ,6-TCP, hicihly supersaturated 
with respect to HAP and highly undersaturated 
with respect to DCPD. The same equilibration 
data were used in the chemical potential plot 
shown in Fig. 5. There is an apparent trend in 
the p(H+)3(po 43-) vs. p(Ca2+)(oH-)2 data, 
indicating that reequilibration produces a 
better fit to the OCP isotherm and diverges from 
the {3-TCP isotherm with increasing equilibration 
nuMher. The equilibrated suspensions are highly 
supersaturated with respect to HAP, even after 
15% of the deposit has dissolved (Exp. E-6). 
This rules out HAP as a major equilibrating 
phase in atherosclerotic deposits. Similar data 
were obtained with other atherosclerotic and 
hioprosthetic deposits. 
Kinetic Interpretation of Dissolution of 
Deposits 
Dissolution of deproteinated aortic deposit 
appears to he a kinetically controlled process. 
As shown above, the thermodynamic solubility of 
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p(H+)3(pQ 4 3 -) 
Fig. 5. CheMical potential plot of p(H+)3(P043-, 
VS:-,,(Ca2+)(0H)2 for repeated equi libratfons of 
deproteinated atherosclerotic deposit 10-Hy. 
oExp. E-8. 20 g/L 1 wl4 H3Po4 , 51 CO2• total bulk 
dissolution 9.51; ,:,.Exp. E-6. 17.5 g/L 20 nfll 
HCL. CO2 = O. total bulk dissolution 351. 
HAP (ref. [28)). ---- OCP (ref. [22)), and 
/3-TCP (ref. [20)) isothenns. 2s 0c. The field 
below a curve represents supersaturation (SS), 
and the field above that curve represents 
undersaturation (US) with respect to the 
indicated solid phase. The first equilibration 
and the last equilibration in sequence are 
numbered. 
OCP: therefore, we attempted to characterize the 
dissolution kinetics using OCP as the dissolu-
tion model. As shown by numerous experiments, 
the rate of equilibration is insensitive to the 
stirring rate, increases with solid/solution 
ratio, and decreases as the relative CO2 
pressure increases. The dissolution process can 
be characterized by the rate equation: 
R = (Ht/Wi )2/3 d( IAP(OCP) )1/8/dt = Kdst.n (1) 
where Kd = rate constant 
(Wt/Wi)2/3 = solid-to-solution correction factor 
t.= ('.AP(OCP)l/8 - Ksp(OCP)l/8) = undersatura-
t1 on parameter 
IAP(OCP) (ca2+)4(po 43-)3(H+) = ionic activity 
product for OCP 
thermodynamic solubility product for 
OCP 
n reaction order and 
s = surface area parameter. 
A typical dissolution-rate profile (Fig. 6a) 
shows that under a given set of conditions (0.5 
g/L 0.2 mM H3P04 , 1% CO2 , 37°C), 70% of OCP 
saturation is accomplished within two hours. 
Kinetic treatment of the the dissolution 
process, given by log-log plots of equation (1 ), 
yields the value of n from the slope (Fig. 6b). 
In general, the dissolution of cardiovascular 
mineral using the OCP dissolution model is 

























6.2 6.4 6.6 6.8 
-LOG t,. 
Fig. 6a-b. Dissolution of atherosclerotic 
deprotefnated deposit sample 7-3-Hy (Exp. D-48, 
0.5 g/l 0.2 nf1I H3P04, 1S CO2, 370C). (a) 
IAP(OCP)l/8 vs. time (kinetic profile); (b) -log 
R vs. -log c. treatment of (a) data, slope n = 
2.3. 
characterized by values of n = 2 to 3. For 
example in the case of Exp. D48, n = 2.3. This 
supports the concept that 11nder these conditions 
dissolution is a surface controlled rate process 
and in this manner parallels the mechanism of 
dissolution of kidney stones [34]. 
Effect of Carbonate on Dissolution of Deposits 
nissolution processes were studied in 
systems saturated with co2/N2 gas mixtures 
ranging from 0.15 to 33% CO2. CO2 in the 
dissolution medium lowers the pH of the 
suspensions, resulting in increased solubility 
of the deposits. On the other hand, increased 
CO2 pressure markedly slows down the rate of 
approach to equilibrium. These events a re 
illustrated in Fig. ?a-c. The changes in 
pIAP(OCP) vs. time reflect the effects of CO2 on 
the rate of approach to equilibrium. The kinetic 
treatment of dissolution data, outlined in the 
preceding section, proves the validity of eq. l 
for characterizing the rlissolution of deposits 
as surface control led rate processes (n = 2-3) 
over the whole range of COz partial pressures. 
Discussion 
Our results provide conclusive information 
on the striking similarity of atherosclerotic 
and bioprosthetic calcified deposits. The 
compositions are in general agreement with 
literature reports on the nature of 
atherosclerotic calcifications [2,23-25]. Our 
data provide a more detailed physicochemical 
characterization, particularly of solubilities 
and dissolution-rate parameters of pathologic 
deposits. The empirical formulae of deposits 
given above are oversimplifications, useful for 
easier comparison of the chemical compositions. 
These formulae do not necessarily provide the 
structural information necessary to conclude 





























Fig. 7a-c. Dissolution of deproteinated 
atherosclerotic deposits. Effect of CO2 partial 
pressure on rate of equilibration. □ 0.151, 
o 1.01, c. 5.01 and • 331 CO2 in co2/N2 gas 
mixture. (a) pH, (b) Ca and (c) pIAP(OCP) 
kinetic profiles. 0.5 g/L 0.2 nf1I H3P04, 37°c. 
structural features and, therefore, a common 
mechanism of formation. 
The spectra of the aortic plaques and 
bioprosthetic calcified deposits - both in their 
native and deproteinated states - are very 
similar and, in fact, closely resemble the 
spectra of other mineralized tis sues (e.g., 
chick bone) studied in previous work [5]. These 
corroborative studies with the Raman mi crop robe 
have provided a consistent picture of the 
composition of these ca 1 cifi ed deposits as 
consisting of a microcrystalline mineral phase 
B.R. Tomazic, E.S. Etz, W.E. Brown 
present in a complex, bio-organic host material, 
with the mineral best described as a 
carbonate-hearing (Type-8), "impure" biological 
apatite different from a stoichiometric HAP. 
The SEM and microprobe rlata inrlicate that, at 
the microscopic level, these calcific rleposits 
clearly show a fair degree of heterogeneity in 
morphology and composition: this is also borne 
out by the Ca/P ratios obtained by x-ray 
microanalysis. Contrary to some predictions 
that such mineralized deposits may also contain 
carbonate moieties substituted for hydroxyl in 
the structure of the biologic apatite, we rlid 
not detect the presence of Type-A carbonate 
apatite in our spectra [16). In ongoing work we 
are closely scrutinizing the vibrational spectra 
(micro-Raman and FT/IR) to possibly reveal the 
presence of OCP and its hydrolyzates whic~ have 
been proposed as precursors, or participants, in 
the formation of cardiovascular calcified 
deposits. 
Solubility rlata complemented with optical 
microscopic data provide the essentially new 
information that cardiovascular calcification 
cannot be representerl as HAP. More plausibly, 
this heterogeneous phase can be representerl as a 
series of· hydrolyzed, carbonate-substituted 
products arising from OCP. The similarity in 
the two types of deposits suggests that they a re 
formerl by similar mechanisms even though the 
atherosclerotic rleposits initiate subintimally 
[2'i], while bioprosthetic rleposits form in 
direct contact with bloorl. The mathematical 
model for calcium phosphate crystal formation 
has been recently provided by Nelson [32]. The 
model includes nucleation sites in tissue in 
which growth is controlled by inhibitors. 
However, the irlentity of precursors/phases was 
not rliscussed. It has been documented that OCP 
(but not HAP) forms in ultrafiltered serum when 
it has been marle supersaturated with respect to 
both OCP and HAP (Eidelman et al., private 
communication). This introduces OCP as a 
possible precursor in cardiovascular deposit 
formation. OCP readily forms in aqueous 
solutions as a kinetically favored, but 
unstable, phase. This finding is in accordance 
with the general scheme of the mechanism of 
biological mineralization, which emphasizes the 
importance of kinetic parameters [30]. The 
formation and conversion of OCP is affected by 
the composition of the solutions; Mg2+ and C□ 1 2 -
markedly stabilize OCP, slowing its hydrol{.s,s: 
and carbonate uptake takes place when C03 - is 
present, resulting in the formation of poorly 
crystallized Type-B carbonate apatite [Ii]. 
These sequential events are presented 
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where OCPH represents an ill-defined product 
obtainerl when OCP hydrolyzes in situ (OCP 
hydro lyza te). 
The above schema is suggested as a model 
for the formation of biological apatites. 
Additional complications are created by the 
presence of a variety of biologically active 
compounds which additionally can control the 
rates of hydrolysis and "maturation" of 
precursors. The final product would, 
consequently, comprise a series of OCP-carbon-
ate-hydrolyza tes, which are generally referred 
to as "defect apatites," in agreement with our 
findings with cardiovascular deposits. 
The presence of OCP in cardiovascular 
deposits has been documented by electron 
diffraction [23). This is in agreement with our 
view that hydrolysis of OCP contributes to the 
heterogeneity of these deposits. The chemical 
potential plots and kinetic data additionally 
support this proposition. The products are 
significantly more soluble than well-crystal-
lized HAP, and one may expect that it is the 
degree of sa tura ti on of blood with respect to 
OCP that controls formation of these deposits. 
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Discussion with Reviewers 
T. H. Jordan: Is it necessary to read reference 
[26] in order to learn how to obtain the 
composition formulas presenter1 in the text? The 
reader is told that nonstoichiometric carbonate 
apatite can be expressed as Ca10-x-y(P04)6-x 
(HP04,C03lx(OHl2-x-2y• The statement is then 
made that the data in Table 2 translates into 
Ca8.66Mgo,22Nao.J2Ho.15(P04)5(C03)1.22 
(OH,Cl,Flo.8, A simple comparison of these 
two formulas, outlined in Results section, sug-
gests: 
From (HP04,C03) x = 1.22 + 0.15 = 1.37 
From (P04) 6 - x = 5 - 0.15 = 4.85 or x = 1.15 
Clearly x cannot have both these values. These 
two values of x would both be 1.26 if the amount 
of H were raised from 0.15 to 0.26, but then 
charge balance would no longer hold. Perhaps 
the (OH) could be adjusted to take this into 
account. If reference [26] does not give an 
explanation, then I would suggest the authors 
give a little more guidance to the reader. 
R.R. Tomazic, E.S. Etz, W.E. Brown 
Authors: The composition formula of 10 hydra-
zine deproteinated atherosclerotic deposits was 
<lerived from chemical analysis of Ca, Mg, Na, 
HP04, P04, C03 contents, which gave average com-
position Ca3_0 5Mgo.22Nao_32Ho.1s(P04)5(C03)1.22-
Charge balance for this composition was 
calculated by summation of positive and negative 
ionic charges: (8.66 x 2 + 0.22 x 2 + 0.32 + 
0.15) - (5 x 3 + 1.22 x 2) = 0.8. The charge 
balance +0.8 was assigned to (OH, F, Cl) 
composition which was the only calculater! group 
of constituents. This mathematical approxi-
mation can be affected by analytical error 
( HP04, C03 up to 5%) or by oversi mp 1 ifi cation of 
the state of carbonate, the portion of which may 
be incorporater! as HC03 group. [This discussion 
can help to accept the calculated gap in X 
value.] 
T.H. Jordan: The SEM data presented in Fig. 
indicate three different types of morphology. 
In reporting the Raman Microprohe Analysis, the 
authors refer to measurements made on several 
arbitrary, single particles. Oid these 
particles include samples of each of the three 
different types of morphology? If so, is there 
any relationship between the carbonate content 
and the morphology? 
Authors: The Raman microprobe spectra of 
single, isolated particles were not correlated 
with the different morphological types of 
calcified deposits recognized by scanning 
e 1 ectron microscopy (cf. Fig 1). Any presumed 
relationship between the microscopic molecular 
composition (e.g., the carbonate content) of 
these deposits and the observed morphological 
characteristics need yet to be examined. 
T.H. Jordan: If one converts the data in Table 
2 to 'J; by weight, one discovers that for (A) 
only 86.7% of the weight of the sample is 
accounted for. What is the rest of the sample? 
The amount unaccounted for is too great to he 
hydroxide or chloride as the formula in Chemical 
Composition section suggests. Yet we are told in 
the Methods section that a quantitative 
deproteination technique was used. What is the 
other 13.3% of the sample? 
Authors: The deproteinated calcified deposits 
are hydrated. Our unpublished TGA data show 
average weight loss of 15% hy heating to 6oooc. 
Reviewer II: Don't the solubility and dissolution 
data presented in this paper suggest that OCP is 
more than just a transient precursor phase which 
initiates mineral formation? That is, don't 
these r!ata indicate that f1CP was still a sizable 
mineral component in the deposits examined? nr 
are the authors suggesting that the hydrolyzer! 
carbonate-substituted "defect apatite" products 
have a solubility product similar to that of the 
OCP precursor? 
Authors: Our data indicate that cardiovascular 
deposit is heterogeneous. A fraction of this 
may be OCP, but at present, we cannot suggest 
the size of the OCP fraction. As shown in Fig. 
4, the solubility range of cardiovascular 
deposits is unexr,ectedly close to that of OCP. 
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We believe that the structural and solubility 
properties of this OCP hydrolyzate comprise two 
of the most important unanswered questions in 
biomineral research. 
The range of sol ubi 1 i ty products of OCPH 
expressed in the terms of OCP is similar to, but 
slightly lower than that of the most probable 
va 1 ue for OCP. A decrease is expected because 
the hydrolysis of OCP in vivo is spontaneous and 
should therefore 1 ead To aproduct with reduced 
solubility. The solubility product of carbonate 
substituted calcium phosphate would certainly 
have a different numerical value than Ks_pOCP, 
but at present we do not know how it should be 
formulated. 
RevfewerII: Do the 3 distinctly different 
morphologies illustrated in the SEM figure (Fig. 
1) represent 3 separate types of mineral 
deposits or the same type of deposit but at 3 
different stages of maturation? 
Authors: SEM figures represent only most 
abundant morpho 1 ogi es; other mi nor morpho 1 ogi es 
are present as wel 1. One can anticipate that 
the surrounding media, i.e., organic matrix 
composition, may greatly affect the maturation 
of inorganic matrix. Therefore, variability of 
morphologies and Ca/P composition is to be 
expected. This suggests that the maturation 
process is continuous. 
Reviewer II: (In reference to Fig. 4) What was 
the pH at the start of the equilibration 
process? Did the authors vary the initial pH 
and, if so, did it have any effect on the final 
equi 1 i bra tion? 
Authors: The deposits were equilibrated with 1 
mM H3P04. The pH of the dissolving medium was 
not preadjusted. Immediately after suspending 
powdered deproteina ted deposit 10-Hy, the pH 
increased sharply due to dissolution of the 
so 1 id. 
Reviewer 1I: If HAP is ruled out as a major 
equ1l1brat1ng phase, what replaces it, OCP or 
the carbonate-containing hydrolytic products of 
OCP? 
Authors: The Ca/P composition of deposits 
var,es from 1.6 1.8. Present solubility 
information rules out HAP as a major 
equilibrating phase. We suggest that 
cardiovascular deposits are best represented as 
a series of carbonate-containing OCP 
hydrolyzates, some OCP as documented by Hohling 
et al. [23], and some material that approaches 
HAP in composition and structure. 
Reviewer II: Please explain or reference how 
values of n between 2 and 3 support a surface 
control led rate process. 
Authors: The rate of stirring did not affect 
the rate of dissolution of cardiovascular 
deposits (present work) or kidney stones [35]. 
This is indicative of a surface-diffusion 
control led rate process. Such processes are 
characterized by values of n = 2 or higher. In 
the opposite case where volume diffusion is the 
rate controlling process, dissolution rate is 
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affecte<1 by the stirring rate and can be 
characterized by a reaction order of n = 1. 
RevfewerII:Would it be too presumptuous to add a 
statement here that the "hydrolyzed, carbonate-
substituted products" are apatitic-like in 
lattice structure and composition hut more akin 
to OCP in so far as solubility behavior is 
concerned? Couldn't such dichotomy in 
properties suggest that the individual particles 
in the deposits are comprised of an apatitic 
core and an OCP-like surface coat? 
Authors: The deprotei na ted deposits were groun<1 
to very fine powder, which very likely exposed 
both "surface coatings" and "cores." Contrary 
to the suggestion, just the opposite might he 
the case---OCP cores trapped in coatings of OCPH 
with varying <1egrees of "maturation." The 
equilibrium solubility data expressed as 
IAP(OCP) indicate a gradual change in solubility 
indicating coexistence of a series of 
OCP-hydrolyzates of variable solubilities. This 
approach does not test the hypothesis that 
apatitic cores or coatings are present, but this 
possibility cannot be rule<1 out. The optical 
microscopy results are not indicative of the 
presence of HAP. 
A.C. Ne1 son: The authors should be clear that 
the mechanism of in vitro dissolution of mineral 
deposits probably~ not characterize the 
mechanism of in vivo deposit formation. For 
example, the eTTectol' formation inhibitors may 
radically alter the formation kinetics. 
Authors: Our solubility data anc1 optical 
m1 croscopi c observations provide es se nti a 1 
information that cardiovascular <1eposi ts arise 
from OCP-like precursors, forme<1 under in vivo 
conditions. The authors certainly realize that 
fonnation inhibitors may radically alter 
formation kinetics. In addition, inhibitors may 
control the mechanism of pa thol ogi c deposition 
by stabilizing unstable (i.e., more soluble) 
precursors, hence preventing formation of 
"mature" deposits. 
A.C. Nelson: More detail on the preparation of 
samples for SEM EDX analysis would be useful 
especially with regard to minimization of 
mineral loss during preparation. 
Authors: The samples for SEM EDX analysis were 
prepared by mechanically crushing hydrazine 
deprotei na ted deposits as outlined in the 
Materials and Methods section. We do not 
anti ci pate significant mi nera 1 1 os ses during 
sample preparation. 
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